Pediatric Prevnar 20 Heads To US Vaccine Schedule As CDC Vaccine Cmte Strives To Streamline

 
• By Bridget Silverman

Advisory Committee on Immunization Practices recommends routine use of the high-valence pneumococcal vaccine in under-2 year olds and older children with risk conditions.

pneumococcal vaccine PCV ACIP
Pfizer and Merck have produced succeedingly higher-valence pneumococcal vaccines for both adult and pediatric use that extend serotype coverage.

More from Vaccines

More from Pink Sheet